Skip to search formSkip to main contentSkip to account menu

proxodolol

Known as: 3-methyl-5-(2-(3-(tert-butylamino)-2-hydroxypropoxy)phenoxymethyl)-1,2,4-oxadiazole 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
A new form of ophthalmic preparations is proposed. A suspension of poly(N-isopropylacrylamide) (poly(NIPAA)) hydrogel is capable… 
2005
2005
Gas chromatography was used to study the pharmacokinetics of Proxodolol eye drops, a new Russian hybrid beta-alpha adrenergic… 
1999
1999
Effects of an original Russian combined preparation proxofelin consisting of 1% proxodolol and 0.25% clofelin solutions on… 
1995
1995
Effects of a Russian b-a-adrenoblocker proxodolol on the intraocular pressure, ocular hemodynamics, pupil diameter, ocular… 
1994
1994
In non-inbred rats, the pharmacokinetics of proxodolol was studied after its intravenous administration in a dose of 1 mg/kg or… 
1994
1994
: The antihypertensive efficacy and hemodynamic effects of the new hybrid (beta-, alpha-) adrenoceptor blocking agent proxodolol… 
1994
1994
The clinical and instrumental investigations of 38 patients with mild and moderate arterial hypertension have shown that therapy… 
1994
1994
The new original Russian drug proxodolol having alpha- and beta-adrenoblocking activities in a ratio of 1:100 was examined at…